Not finding it? Sign in to also search OpenAlex live.
-
TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol
Ellis Niemantsverdriet, Yousra J. Dakkak, Leonie E. Burgers, Femke Bonte‐Mineur, Gerda M. Steup‐Beekman, Sjoerd M. van der Kooij, +4 more
35citations -
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer
Jaume Capdevila, Arkadiy L. Klochikhin, Sophie Leboulleux, Pavel A. Isaev, Corin Badiu, Bruce Robinson, +12 more
20citations -
Laparoscopic versus open parenchymal preserving liver resections in the posterosuperior segments (ORANGE Segments): a multicentre, single-blind, randomised controlled trial2025 The Lancet Regional Health - Europe article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Jasper P. Sijberden, Christoph Kuemmerli, Francesca Ratti, Mathieu D’Hondt, Robert Peter Sutcliffe, Roberto Ivan TROISI, +22 more
14citations -
Blind Signal Recognition Method of STBC Based on Multi-channel Convolutional Neural Network2022 IEEE Vehicular Technology Conference conference-paper Computer Science Wireless Signal Modulation Classification
Yuting Guy, Yu Wangy, Bamidele Adebisiz, Guan Guiy, Haris Gacaninyy, Hikmet Sariy
3citations -
LB0010 INHIBITION OF STRUCTURAL DAMAGE PROGRESSION WITH GUSELKUMAB, A SELECTIVE IL-23i, IN PARTICIPANTS WITH ACTIVE PsA: RESULTS THROUGH WEEK 24 OF THE PHASE 3b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED APEX STUDY2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Philip J. Mease, Christopher T. Ritchlin, Laura C. Coates, A. Kollmeier, Bin Zhou, Y. Jiang, +4 more
3citations -
Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies2026 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Xenofon Baraliakos, Walter P. Maksymowych, Victoria Navarro‐Compán, Désirée M F M van der Heijde, Robert Landewé, Pedro Machado, +10 more
1citations -
PO.6.137 Design of a phase 2, multicenter, randomized, placebo-controlled, parallel-group, double-blind study to assess the efficacy and safety of nipocalimab in adults with active systemic lupus erythematosus
Fang Liu-walsh, Bart van Hartingsveldt, Qing Zuraw, RW Hoffman, Terence P. Rooney, Sheng Gao, +6 more
0citations -
Limited Efficacy of 3 mA Intensified tDCS of the Right Inferior Frontal Cortex for OCD Treatment: A Randomized, Double‐Blind, Sham‐Controlled Study2026 CNS Neuroscience & Therapeutics article Psychology Obsessive-Compulsive Spectrum Disorders Open access
Atefeh Fatehi-chenar, Mohsen Dadashi, Alireza Moradi, Soroush Lohrasbi, Abolfazl Ghoreishi, Arash Fazeli, +4 more
0citations -
A tablet-based attentional cognitive bias modification intervention for positive emotion processing in major depressive disorder: a single-blind randomised controlled two-centre trial2026 EBioMedicine article Psychology Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Open access
Z. Kratochwil, J. Kesik, Duygu Keskin Gökçelli, Katrin Sakreida, Norbert Scherbaum, Bernhard W. Müller, +1 more
0citations -
Correction: Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, Randomized-Controlled Feasibility Trial
Manouk den Toom, Laura M. E. Blanken, Inge Horn, Selene R. T. Veerman, Joris J. B. van der Vlugt-Molenaar, Mariken Beatrijs de Koning, +14 more
0citations -
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Atul A. Deodhar, Paula Śliwińska-Stańczyk, Huji Xu, Xenofon Baraliakos, Lianne S. Gensler, Dona L. Fleishaker, +8 more
260citations -
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Jonathan Barratt, Richard A. Lafayette, Jens Halkjaer Kristensen, Andrew M. Stone, Daniel Cattran, Jürgen Floege, +90 more
226citations -
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan2020 Journal of the American Society of Nephrology article Medicine Erythropoietin and Anemia Treatment Open access
Tadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, Yoshikatsu Majikawa
208citations -
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
Andrew Paul Cope, Marianna Jasenecova, Joana Carvalho Vasconcelos, Andrew D. Filer, Karim Raza, Sumera Qureshi, +61 more
182citations -
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial2022 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Maarten Boers, Linda M. Hartman, Daniela Opriș-Belinski, Reinhard Bos, Marc R. Kok, José António Pereira da Silva, +14 more
166citations -
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul A. Deodhar, Robert Davies Inman, Hideto Kameda, +6 more
129citations